Genomate Health will join the international health innovation community at Frontiers Health 2026 in Berlin on October 20–21. Dr. Istvan Petak, Founder and Chief Scientific Officer, will attend to connect with investors, pharmaceutical companies, and potential partners exploring the future of precision medicine.

‍

This year’s program covers personalized healthcare, AI, advances in molecular science, and strategies for funding and scaling health innovation. These conversations reflect a central challenge for our field: turning increasingly complex biological information into insights that can support meaningful decisions. Frontiers Health offers an opportunity to exchange perspectives on how these capabilities can contribute to research and care, and to explore the collaborations needed to bring them into wider use.

At Genomate Health, we develop computational reasoning technology to help interpret the molecular mechanisms driving cancer and identify potential treatment opportunities. Our work connects precision oncology with drug development, exploring how a better understanding of tumor biology can help identify patient populations for new and existing therapies. Dr. Petak looks forward to meeting teams working at the intersection of oncology, pharmaceutical innovation, and computational medicine.

‍

Attending Frontiers Health? Get in touch  to arrange a meeting with Istvan ↗